Seroquel Long-Term NIS for Schizophrenia Patients
NCT00523783 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2008-10-06
Summary
To assess the efficacy of 24-week treatment with quetiapine in patients with schizophrenia or schizoaffective disorder
Conditions
- Schizophrenia
- Schizoaffective Disorder
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Joon-Woo Bahn · AstraZeneca Korea
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-05-31
- Primary Completion
- 2007-11-30
- Completion
- 2008-05-31
Countries
- South Korea
Study Locations
More Related Trials
-
SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia
NCT00206115 ·Status: COMPLETED ·Phase: PHASE3
-
High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder
NCT00297947 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic Patients
NCT00882518 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Seroquel vs. Risperidone in Schizophrenia
NCT00034905 ·Status: COMPLETED ·Phase: PHASE4
-
A Retrospective Non-interventional Study to Evaluate the Use of Seroquel Extended Release (XR) and Immediate Release (IR) in the Clinical Practice of Inpatients With Schizophrenia
NCT01214135 ·Status: COMPLETED
-
Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects
NCT00328978 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Quetiapine in Treating Affective Symptoms of Patients With First-episode psychosis-a Pilot Study
NCT00511277 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Broad Clinical Benefit for Seroquel XR With Flexible Dose as an add-on Therapy in the Treatment of Acute Bipolar Mania Patients With Partial Response to Current Therapy
NCT01128114 ·Status: TERMINATED ·Phase: PHASE4
-
Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia
NCT00255515 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia
NCT00817648 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR)
NCT00779506 ·Status: COMPLETED ·Phase: PHASE4
-
Seroquel (Quetiapine Fumarate) InPractice Evaluation Programme
NCT00921362 ·Status: COMPLETED
-
Effect of Quetiapine on Negative Symptoms and Cognition
NCT00305422 ·Status: COMPLETED ·Phase: PHASE3
-
Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia
NCT00981123 ·Status: COMPLETED
-
Quetiapine Extended Release Depression Symptoms
NCT00640562 ·Status: COMPLETED ·Phase: PHASE3
-
Quetiapine in the Treatment of Psychotic Depression - a Pilot Study
NCT00751504 ·Status: COMPLETED ·Phase: PHASE3
-
Seroquel Switching Study: Feasibility of Switching Any Antipsychotic Treatment to Seroquel in Patients With Schizophrenia
NCT00234377 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia
NCT00954122 ·Status: COMPLETED ·Phase: PHASE4
-
Compare the Effect on Cognitive Functioning of Two Formulations of Seroquel, Seroquel XR and IR in Patients With Stable Schizophrenia
NCT01213836 ·Status: COMPLETED ·Phase: PHASE4
-
Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic Patients
NCT00254787 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression
NCT01256177 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar Disorder
NCT00837343 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.
NCT04115319 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Seroquel XR on Sleep Architecture in Patients With Major Depressive Disorder
NCT01189318 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder
NCT00156715 ·Status: COMPLETED ·Phase: PHASE4